Eisner Mark sold VIR
February 23, 2026 · Form 4 insider transaction
Eisner Mark sold 2,089 shares of Vir Biotechnology, Inc. at $7.45 per share, a transaction worth $15.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,089
Price
$7.45
Total value
$15.6K
InsiderEisner Mark
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 23, 2026
Filing dateFebruary 24, 2026
Shares owned after157,529
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.